Search Results 611-620 of 18295 for peptides

  1. Innovative options for medically refractory epilepsy - Mayo Clinic

    ... peptide. Mayo Clinic was actively involved in designing clinical trials for these medications and analyzing the resulting data. In addition, our ...

  2. Publications - Basar Sareyyupoglu, M.D. - Mayo Clinic

    B-type natriuretic peptide levels and continuous-flow left ventricular assist devices. ASAIO J. 2010 Nov-Dec; 56 (6):527-31. View PubMed; Sareyyupoglu B ...

  3. A Study Of The Effect Of IW-1973 On The Exercise Capacity Of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) - Mayo Clinic

    Elevated B-type natriuretic peptide (BNP) or N-terminal pro b-type natriuretic peptide (NT-proBNP) within the past 6 months;; Echocardiographic evidence ...

  4. Focus Areas - Phospholipid Signaling in Embryonic Development and Human Diseases: Kun Ling - Mayo Clinic Research

    Mayo Clinic's Phospholipid Signaling in Embryonic Development and Human Diseases Lab led by Kun Ling, Ph.D., studies phosphoinositide species and enzymes in ...

  5. Comparison of the Atmo Motility Gas Capsule System to the Reference Standard - Mayo Clinic

    Patients on long-acting glucagon-like peptide (GLP-1). Active implantable devices (e.g., gastric stimulator, pacemaker, defibrillator) [continuous glucose ...

  6. Cardiovascular Medicine - Doctors - Mayo Clinic

    Redfield, M.D.. Internist; Cardiologist. Rochester, MN. Areas of focus: Brain natriuretic peptide test, Heart failure, Cardiomyopathy, Pulmonary hypertension, ...

  7. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

  8. Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes - Mayo Clinic

    Fasting serum C-peptide < 1 ng/mL (333pmol/l). Current use of insulin, or previous use of any types of insulin for > 1 month at any time (except for ...

  9. Study of Oral LOXO-338 in Patients With Advanced Blood Cancers - Mayo Clinic

    in the absence of volume depletion. - N-terminal pro hormone natriuretic peptide (NT-proBNP) > 8500 ng/L (or BNP > 700 ng/L if NT-proBNP is not available by ...

  10. A Study Comparing 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR to Treat Patients with Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours - Mayo Clinic

    Peptide receptor radionuclide therapy (PRRT) at any time prior to randomization in the study. Any surgery, radioembolization, chemoembolization ...